{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:02:44Z","timestamp":1757620964284,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1990,4,1]],"date-time":"1990-04-01T00:00:00Z","timestamp":638928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[1990,4]]},"DOI":"10.1016\/0026-0495(90)90265-e","type":"journal-article","created":{"date-parts":[[2004,4,19]],"date-time":"2004-04-19T01:36:25Z","timestamp":1082338585000},"page":"13-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Role of 1,25(OH)2D in the genesis of secondary hyperparathyroidism of early renal failure and its use in the prevention of this abnormality"],"prefix":"10.1016","volume":"39","author":[{"given":"Shaul G.","family":"Massry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0026-0495(90)90265-E_BIB1","first-page":"104","article-title":"Experience with radioimmunoassay of parathyroid hormone in human sera","volume":"81","author":"Reiss","year":"1968","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/0026-0495(90)90265-E_BIB2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/00002480-197201000-00103","article-title":"Turnover of endogenous parathyroid hormone in uremic patients and those undergoing hemodialysis","volume":"18","author":"Massry","year":"1972","journal-title":"Trans Am Soc Artif Int Organs"},{"key":"10.1016\/0026-0495(90)90265-E_BIB3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/ki.1973.87","article-title":"Hyperparathyroidism and renal failure","volume":"4","author":"Arnaud","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/ki.1976.42","article-title":"Bone histology in incipient and advanced renal failure","volume":"9","author":"Malluche","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archinte.1969.00300150061009","article-title":"Calcium, phosphorus and bone in renal disease and transplantation","volume":"123","author":"Bricker","year":"1969","journal-title":"Arch Intern Med"},{"key":"10.1016\/0026-0495(90)90265-E_BIB6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/archinte.1980.00330190042017","article-title":"Effects of long-term therapy with 1,25(OH)2D3 in patients with moderate renal failure","volume":"140","author":"Healy","year":"1980","journal-title":"Arch Intern Med"},{"key":"10.1016\/0026-0495(90)90265-E_BIB7","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic and experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J Clin Invest"},{"key":"10.1016\/0026-0495(90)90265-E_BIB8","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.1972.84","article-title":"On the prevention of secondary hyperparathyroidism in experimental chronic renal disease using \u201cproportional reduction\u201d of dietary phosphorus intake","volume":"2","author":"Slatopolsky","year":"1972","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB9","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/ki.1973.92","article-title":"The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease","volume":"4","author":"Slatopolsky","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7326\/0003-4819-78-3-357","article-title":"Skeletal resistance to parathyroid hormone in renal failure: Study in 105 human subjects","volume":"78","author":"Massry","year":"1973","journal-title":"Ann Intern Med"},{"key":"10.1016\/0026-0495(90)90265-E_BIB11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ki.1974.62","article-title":"Divalent ion metabolism in patients with acute renal failure: Studies on mechanism of hypocalcemia","volume":"5","author":"Massry","year":"1974","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1210\/jcem-41-2-339","article-title":"Skeletal resistance to endogenous parathyroid hormone in patients with early renal failure: A possible cause for secondary hyperparathyroidism","volume":"41","author":"Llach","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/0026-0495(90)90265-E_BIB13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1210\/jcem-61-4-601","article-title":"On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency","volume":"61","author":"Llach","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/0026-0495(90)90265-E_BIB14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/ki.1973.40","article-title":"Study of intestinal absorption of calcium in patients with renal failure","volume":"3","author":"Coburn","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ki.1973.88","article-title":"Intestinal absorption of calcium and the effect of renal insufficiency","volume":"4","author":"Coburn","year":"1973","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB16","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1172\/JCI105500","article-title":"Further studies on inter-relationship between parathyroid hormone and vitamin D","volume":"45","author":"Arnaud","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/0026-0495(90)90265-E_BIB17","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/ki.1976.60","article-title":"Skeletal resistance to the calcemic action of parathyroid hormone in uremia: Role of 1,25(OH)2D3","volume":"9","author":"Massry","year":"1976","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ki.1985.48","article-title":"Altered divalent ion metabolism in early renal failure: Role of 1,25(OH)2D","volume":"27","author":"Wilson","year":"1985","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB19","first-page":"733A","article-title":"Low serum levels of 1,25(OH)2D are not responsible for the development of secondary hyperparathyroidism in early renal failure","volume":"14","author":"Slatopolsky","year":"1978","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB20","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ki.1983.131","article-title":"Determinations of serum 1,25(OH)2D levels in renal disease","volume":"24","author":"Cheung","year":"1983","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB21","series-title":"Clinical Disorders of Bone and Mineral Metabolism","first-page":"260","article-title":"Use of 1,25(OH)2D3 in the treatment of renal osteodystrophy in patients with moderate renal failure","author":"Massry","year":"1983"},{"key":"10.1016\/0026-0495(90)90265-E_BIB22","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ki.1982.9","article-title":"Circulating vitamin D metabolite concentration in childhood renal disease","volume":"21","author":"Chesney","year":"1982","journal-title":"Kidney Int"},{"key":"10.1016\/0026-0495(90)90265-E_BIB23","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI111365","article-title":"Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency","volume":"73","author":"Portale","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1016\/0026-0495(90)90265-E_BIB24","series-title":"Clinical Disorders of Bone and Mineral Metabolism","first-page":"267","article-title":"Marked suppression of secondary hyperparathyroidism (SH) by intravenous 1,25(OH)2D3 in uremic patients","author":"Slatopolsky","year":"1983"},{"key":"10.1016\/0026-0495(90)90265-E_BIB25","first-page":"13A","article-title":"The effects of 1,25(OH)2D3 on PTH secretion by monolayer cultures of bovine parathyroid (PT) cells","volume":"17","author":"Chan","year":"1984"},{"key":"10.1016\/0026-0495(90)90265-E_BIB26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1210\/endo-104-1-248","article-title":"The acute effects of 1,25-dihydroxycholecalciferol on serum immunoreactive parathyroid hormone in the dog","volume":"104","author":"Oldham","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/0026-0495(90)90265-E_BIB27","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1210\/jcem-53-4-823","article-title":"Suppressive effect of 1,25-dihydroxyvitamin D3 on circulating parathyroid hormone in acute renal failure","volume":"53","author":"Madsen","year":"1981","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/0026-0495(90)90265-E_BIB28","first-page":"24A","article-title":"Hypocalcemia may not be the cause of the development of secondary hyperparathyroidism","volume":"17","author":"Lopez","year":"1984"},{"key":"10.1016\/0026-0495(90)90265-E_BIB29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1989.36","article-title":"1,25(OH)2D3 administration in moderate renal failure: A prospective double-blind trial","volume":"35","author":"Baker","year":"1989","journal-title":"Kidney Int"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:002604959090265E?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:002604959090265E?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T11:15:46Z","timestamp":1757330146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/002604959090265E"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["002604959090265E"],"URL":"https:\/\/doi.org\/10.1016\/0026-0495(90)90265-e","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[1990,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 1,25(OH)2D in the genesis of secondary hyperparathyroidism of early renal failure and its use in the prevention of this abnormality","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/0026-0495(90)90265-E","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1990 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}